Key facts
- It has raised $45.4M across 9 recorded rounds; the latest was Seed Round ($1.6M) in Mar 2025.
- Notable investors include Byron Georgiou, Delta Global (Maimi).
- ForeSee Medical has filed 30 Form Ds with the SEC since 2017, most recently Apr 2025 ($1.6M sold to 21 investors).
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 9 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for ForeSee Medical
Funding rounds
9 roundsAbout ForeSee Medical
Developer of a healthcare data management platform designed to facilitate clinical guidance and simplify and automate the care delivery process. The company's platform uses proprietary disease algorithms and machine-learning natural language processing to rationalize patient data across the healthcare system, enabling doctors to get insightful hierarchical condition category risk adjustment assistance and integrate it seamlessly with the electronic health record.
- Sector
- Healthcare
- HQ
- San Diego, CA, United States
- Founded
- 2017
- Employees
- 23
- Website
- foreseemed.com/
- Ownership
- Privately Held (backing)
ForeSee Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ForeSee Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ForeSee Medical in its N-PORT filings yet. We sweep new filings monthly.